Directs the Secretary of Health and Human Services, acting through the National Institute of Arthritis, Metabolism, and Digestive Diseases, to: (1) conduct a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis; and (2) report to Congress within one year of enactment of this Act.
Introduced in House
Introduced in House
Referred to House Committee on Energy and Commerce.
Referred to Subcommittee on Health and the Environment.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line